The street leaned bearish this week. Downgrades outnumbered upgrades, with JP Morgan accounting for the bulk of the action — cutting across real estate, software, and payments in a single sweep. Tech and REITs drew the most concentrated analyst attention. A handful of bold upgrades in healthcare and consumer cut against the cautious tone.
Key Rating Changes
Upgrades
Morgan Stanley upgrades WST to Overweight, raising its price target to $400 from $365. That implies 9.6% upside from last Friday's close.
Cantor Fitzgerald upgrades OMER to Overweight with a $22 price target. Short interest stands at 17.5% of free float, down 18.6% over the past month.
JP Morgan upgrades GPK to Overweight, though it cuts its price target to $11.50 from $12.50. Short interest sits at 7.7% of free float, up 6.3% in a month.
JPMorgan upgrades BP to Overweight in a conviction shift on the energy major.
Stifel upgrades MSFT to Buy, raising its target to $575. Three other price target hikes landed within days. Consensus remains bullish at $577.
Bernstein upgrades PWR to Outperform, lifting its target to $775 from $748.
JP Morgan upgrades EGP to Overweight with a $231 target, implying 14% upside. Short interest has climbed 34% in a month to 5.7% of free float.
BNP Paribas upgrades NBIS to Outperform with a $399 target — 53% above the prior estimate. Short interest remains elevated at 20.8% of free float.
JP Morgan upgrades WELL to Overweight with a $260 target. Short interest is at a recent low of 2.6% of free float.
JP Morgan upgrades REG to Overweight with an $83 target. Short interest has climbed 18.4% in a month to 3.46% of free float.
HSBC upgrades DG to Buy with a $160 target, implying 28% upside from $120.60.
Barclays upgrades HUM to Overweight with a $515 target — 35% upside from the $380 close.
BNP Paribas upgrades SNPS to Neutral from Underperform, setting a $420 target. HSBC goes further, lifting SNPS to Buy with a $700 target — 65% upside from $425. Two firms, two different calls, same week.
JP Morgan upgrades CRWV to Overweight, raising its target to $125 from $120. Short interest has surged 19.5% month-over-month to 17.95% of free float.
Truist Securities upgrades FFBC to Buy, raising its target to $37 from $35. That implies 17% upside from $31.55.
Bernstein upgrades MMM to Market Perform, raising its target 18% to $171.
Wolfe Research upgrades FRVO to Outperform with a $29 target. The geothermal energy name trades at $16.71.
Roth Capital upgrades AGO to Buy, raising its target 6.25% to $85.
Susquehanna upgrades RXO to Neutral from Negative. Target is cut to $19 from $20, still implying 4% downside from $19.79.
JP Morgan upgrades PAYX to Neutral from Underweight, raising its target 9.5% to $115.
Downgrades
Jefferies downgrades VLO to Hold with a $401 target. Short interest is 3.3% of free float, down 8% in a month.
Jefferies downgrades MPC to Hold. Two major US refiners cut in the same session.
HSBC downgrades NFLX to Hold, cutting its target 21% to $76. The firm cites transition headwinds as consensus tilts cautious.
Raymond James downgrades ARX to Underperform. The analyst flags slowing third-party premium mix and investment income headwinds despite 74% revenue growth reported in August.
Wolfe Research downgrades ALV to Peer Perform from Outperform. Analyst Emmanuel Rosner cites demand uncertainty and margin risks in automotive safety.
JP Morgan downgrades WVE to Neutral as the biotech faces clinical and competitive pressures. Short interest sits at 10% of free float.
UBS downgrades PCG to Neutral, cutting its target 26% to $14. The stock is down 27% in one month amid regulatory headwinds.
William Blair downgrades CBZ to Market Perform from Outperform. Consensus is now Hold with minimal upside at $54.68.
Piper Sandler downgrades ROL to Neutral, slashing its target to $33 from $46 — implying 28% downside from current levels.
HSBC downgrades TWLO to Reduce with a $211 target, implying 30% downside from $299.66. The stock surged 35% in a month. Short interest jumped 54% over the same period to 3.9% of free float.
Argus Research downgrades YUM to Hold as the street reassesses the outlook.
Argus Research downgrades QSR to Hold from Buy. The stock is down 13% over the past month at $70.91.
Scotiabank downgrades O to Sector Perform, cutting its target to $59 from $67. Short interest has climbed 1.9% over the past week to 4.37% of free float.
JP Morgan downgrades ALKT to Underweight, slashing its target 42% to $14 from $24.
JP Morgan downgrades VICI to Neutral with a $30 target, stepping back from Overweight. The stock is down 10.6% in a month.
JP Morgan downgrades ARE to Underweight with a $56 target amid rising short interest and earnings headwinds.
JP Morgan downgrades GLPI to Neutral with a $46 target. The stock is down 9.9% this month.
JP Morgan downgrades SAFE to Underweight with a $14 target. The stock is already down 16% this month.
JP Morgan downgrades SKT to Neutral with a $39 target. Short interest has risen 26% in a month to 6.0% of free float.
JP Morgan downgrades KRG to Underweight with a $27 target, below the current price of $24.69.
Citigroup downgrades DBX to Sell with a $29 target, down 12% from the prior $33 call. Short interest stands at 13.4% of free float.
KeyBanc downgrades CMCSA to Underweight with an $18 target — a 19% cut from the prior level.
Jefferies downgrades GPOR to Hold, cutting its target to $180 from $239. Short interest surged 24% in a single day to 6.6% of free float.
Sector Themes
REITs Bear the Brunt
JP Morgan ran a sweeping reset across real estate this week. The bank cut VICI, ARE, GLPI, SAFE, SKT, and KRG in what amounts to a sector-wide reassessment. Regulatory headwinds, earnings pressure, and rising short interest feature across the cuts. The sole REIT upgrade — EGP to Overweight — came from the same bank, suggesting selective rather than wholesale pessimism. REG also received a JP Morgan upgrade despite a sharp rise in short interest, adding to the mixed picture within retail REITs.
Refiners Under Pressure
Jefferies cut both VLO and MPC to Hold in the same session. Refiner margins have been a persistent concern this quarter, and the double downgrade signals the bank sees limited near-term recovery. Short interest in VLO is falling, suggesting some investors are covering rather than pressing the bearish case.
Tech: Divided Conviction
MSFT drew four bullish price target moves in one week, with Stifel's upgrade the headline action. SNPS drew conflicting calls — BNP Paribas moved to Neutral while HSBC went straight to Buy with a 65% upside target. CRWV earned a JP Morgan upgrade even as short interest hit its highest level in weeks. TWLO was the cautionary tale — up 35% in a month, then hit with an HSBC Reduce rating and 30% implied downside.
Consumer & Fast Food Fade
Argus Research cut both YUM and QSR to Hold within two days. Combined with Bank of America slashing its NKE target by 36% ahead of October earnings, the consumer discretionary picture looks increasingly strained heading into Q3 results season.
How this article was generated
Generated
28 Sept 2026, 13:20
Prompt version
v1.0
Data sources
Analyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
JP Morgan Dominates a Week of REIT Resets and Tech Conviction | ORTEX News
